These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16091251)

  • 1. Coronary heart disease in HIV-infected patients.
    Glesby MJ
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):68-73. PubMed ID: 16091251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?].
    Duong M; Cottin Y; Froidure M; Petit JM; Piroth L; Zeller M; L'huillier I; Fargeot A; Mahrousseh M; Chavanet P; Wolf JE; Portier H
    Ann Cardiol Angeiol (Paris); 2003 Nov; 52(5):302-7. PubMed ID: 14714344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary heart disease in people infected with HIV.
    Malvestutto CD; Aberg JA
    Cleve Clin J Med; 2010 Aug; 77(8):547-56. PubMed ID: 20682517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
    Bergersen BM
    Drugs; 2006; 66(15):1971-87. PubMed ID: 17100407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and coronary heart disease: time for a better understanding.
    Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
    J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
    Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
    Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.
    May M; Sterne JA; Shipley M; Brunner E; d'Agostino R; Whincup P; Ben-Shlomo Y; Carr A; Ledergerber B; Lundgren JD; Phillips AN; Massaro J; Egger M
    Int J Epidemiol; 2007 Dec; 36(6):1309-18. PubMed ID: 17652317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
    Stein JH
    Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options.
    Tebas P
    J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S86-92. PubMed ID: 18725817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction.
    Pedersen KK; Pedersen M; Trøseid M; Gaardbo JC; Lund TT; Thomsen C; Gerstoft J; Kvale D; Nielsen SD
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):425-33. PubMed ID: 23797689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.
    Lang S; Boccara F; Mary-Krause M; Cohen A
    Arch Cardiovasc Dis; 2015 Mar; 108(3):206-15. PubMed ID: 25725995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
    Florescu D; Kotler DP
    Antivir Ther; 2007; 12(2):149-62. PubMed ID: 17503657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and management of cardiovascular disease in patients with HIV.
    Nou E; Lo J; Hadigan C; Grinspoon SK
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):598-610. PubMed ID: 26873066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
    De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL
    Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risks of antiretroviral therapies.
    Mondy K; Tebas P
    Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.